Answers are grounded in this paper and cite their sources.
Background: Modern obstetrics uses several methods to relieve pain in pregnant women during labour and childbirth. Labour epidural analgesia (LEA) is an increasingly recognized and accepted method for pain relief. A pain free mother giving birth of a healthy child is the main focus of labour analgesia. The objective of the current study was to assess the effects of labour epidural analgesia on maternal and neonatal outcome.Methods: This retrospective observational study was conducted in labour suit of BRB Hospital Limited, Panthapath, Dhaka, Bangladesh from January, 2020 to June, 2021. A total of 200 parturient received labour epidural analgesia at first stage of labour/s. Continuous epidural infusion of 0.0625% bupivacaine with fentanyl 2μg/ml @ 10ml/hour was given after 15-20 ml bolus of 0.1% bupivacaine and continued upto second stage of labour. The duration of labour, mode of delivery and the APGAR score, NICU admission of neonate were measured.Results: Out of 200 parturient, 166 (83%) were primigravidae and 34 (17%) were multigravidae. The average age of patients was 25 years (median, IQR 20-34 years). Average gestational age of parturient was 38.56 ± 1.25 weeks. The duration of labour was within normal range in 99% of patients. The rate of normal vaginal delivery, instrumental delivery and caesarean section were171 (85.5%), 19 (9.5%) and 10 (5%) respectively. APGAR score (>7) in 1st and 5th minute were 186 (93%) and 197 (98.5%) respectively. NICU admission was not reported.Conclusion: Labour epidural analgesia has no effect on progression of labour and does not alter the mode of delivery. It is associated with better APGAR score of the newborn.
No takes yet. Share an insight, caveat, or question.
Kamal et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: